Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 40, Issue 4, Pages 554-566Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-020-00778-7
Keywords
Primary Myelofibrosis; Rho GTPases; bone marrow microenvironment
Categories
Funding
- NICHD NIH HHS [R01 HD095798] Funding Source: Medline
- NIDDK NIH HHS [R01 DK103794] Funding Source: Medline
Ask authors/readers for more resources
Studies of genetic blood disorders have advanced our understanding of the intrinsic regulation of hematopoiesis. However, such genetic studies have only yielded limited insights into how interactions between hematopoietic cells and their microenvironment are regulated. Here, we describe two affected siblings with infantile myelofibrosis and myeloproliferation that share a common de novo mutation in the Rho GTPase CDC42 (Chr1:22417990:C>T, p.R186C) due to paternal germline mosaicism. Functional studies using human cells and flies demonstrate that this CDC42 mutant has altered activity and thereby disrupts interactions between hematopoietic progenitors and key tissue microenvironmental factors. These findings suggest that further investigation of this and other related disorders may provide insights into how hematopoietic cell-microenvironment interactions play a role in human health and can be disrupted in disease. In addition, we suggest that deregulation of CDC42 may underlie more common blood disorders, such as primary myelofibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available